In our prospective study on men selected for initial prostate biopsy on the basis of PSA values or DRE results, SelectMDx score was positive in 94.1 and 100% of PCa and csPCa, respectively, and in only 8.6% of cases with no PCa at biopsy. This evidence concerns the gene KLK3 and posterior cortical atrophy.